Quaker BioVentures
Description
Quaker BioVentures, operating under the umbrella of Quaker Partners, was a prominent Philadelphia-based venture capital firm specializing in life science investments. Established with a clear focus on the burgeoning biotechnology, pharmaceuticals, medical devices, and healthcare services sectors, the firm became a significant player in the East Coast venture ecosystem. Over its active investment period, Quaker Partners successfully raised over $1 billion in capital commitments across four distinct funds, demonstrating substantial financial backing for its strategic initiatives. Their commitment to the sector was evident through their substantial capital raises, with their final fund, Quaker BioVentures IV, closing at $400 million in 2012.
Investor Profile
Quaker BioVentures has backed more than 57 startups, with 0 new investments in the last 12 months alone. The firm has led 16 rounds, about 28% of its total and boasts 20 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series D, Series A rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series C (21%)
- Series D (19%)
- Series A (19%)
- Series B (18%)
- Series Unknown (9%)
- Post Ipo Equity (4%)
- Series F (4%)
- Series E (4%)
- Debt Financing (2%)
- Seed (2%)
Country Focus
- United States (100%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Health Diagnostics
- Medical Device
- Biopharma
- Manufacturing
- Clinical Trials
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
